Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry

The isoxazolidine ring represents one of the privileged structures in medicinal chemistry, and there have been an increasing number of studies on isoxazolidine and isoxazolidine-containing compounds. Optimization of the 1,3-dipolar cycloaddition (1,3-DC), original methods including electrophilic or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chemical reviews 2016-12, Vol.116 (24), p.15235-15283
Hauptverfasser: Berthet, Mathéo, Cheviet, Thomas, Dujardin, Gilles, Parrot, Isabelle, Martinez, Jean
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 15283
container_issue 24
container_start_page 15235
container_title Chemical reviews
container_volume 116
creator Berthet, Mathéo
Cheviet, Thomas
Dujardin, Gilles
Parrot, Isabelle
Martinez, Jean
description The isoxazolidine ring represents one of the privileged structures in medicinal chemistry, and there have been an increasing number of studies on isoxazolidine and isoxazolidine-containing compounds. Optimization of the 1,3-dipolar cycloaddition (1,3-DC), original methods including electrophilic or palladium-mediated cyclization of unsaturated hydroxylamine, has been developed to obtain isoxazolidines. Novel reactions involving the isoxazolidine ring have been highlighted to accomplish total synthesis or to obtain bioactive compounds, one of the most significant examples being probably the thermic ring contraction applied to the total synthesis of (±)-Gelsemoxonine. The unique isoxazolidine scaffold also exhibits an impressive potential as a mimic of nucleosides, carbohydrates, PNA, amino acids, and steroid analogs. This review aims to be a comprehensive and general summary of the different isoxazolidine syntheses, their use as starting building blocks for the preparation of natural compounds, and their main biological activities.
doi_str_mv 10.1021/acs.chemrev.6b00543
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03572301v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4290044231</sourcerecordid><originalsourceid>FETCH-LOGICAL-a506t-35ceca49945f518237ae6523ae027fd540dd187d1d9cecb139afcd4cde81fdf3</originalsourceid><addsrcrecordid>eNqNkUtrGzEUhUVJqR2nv6AQBrJpFuPoMXdGys6Ypja4pBDvhayHozAeOZJtkv76yrHrQhehq4su3zn3oIPQF4KHBFNyo3Qa6ke7inY3rBcYQ8U-oD4BisuaC3yG-hhjUdK6hh46T-kpPwFo8wn1aCM44Yz10WSawov6FVpvfGdvi1HxM_qdb-3SmuJBK-dCawoXYnEfl6rzulCdKX5Y47XvVFuMcwCfNvH1An10qk3283EO0Pzu23w8KWf336fj0axUgOtNyUBbrSohKnBAOGWNsjVQpiymjTNQYWMIbwwxIoMLwoRy2lTaWE6ccWyArg-2j6qV6-hXKr7KoLycjGZyv8MMGsow2ZHMfj2w6xietzZtZI6qbduqzoZtkvmOEBwY8P9Agda8YTnpAF39gz6Fbcx_8UZVtAIQe0N2oHQMKUXrTmEJlvv6ZK5PHuuTx_qy6vLovV2srDlp_vSVgZsDsFf_vfuO5W_uzKcY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1854245598</pqid></control><display><type>article</type><title>Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry</title><source>ACS Publications</source><source>MEDLINE</source><creator>Berthet, Mathéo ; Cheviet, Thomas ; Dujardin, Gilles ; Parrot, Isabelle ; Martinez, Jean</creator><creatorcontrib>Berthet, Mathéo ; Cheviet, Thomas ; Dujardin, Gilles ; Parrot, Isabelle ; Martinez, Jean</creatorcontrib><description>The isoxazolidine ring represents one of the privileged structures in medicinal chemistry, and there have been an increasing number of studies on isoxazolidine and isoxazolidine-containing compounds. Optimization of the 1,3-dipolar cycloaddition (1,3-DC), original methods including electrophilic or palladium-mediated cyclization of unsaturated hydroxylamine, has been developed to obtain isoxazolidines. Novel reactions involving the isoxazolidine ring have been highlighted to accomplish total synthesis or to obtain bioactive compounds, one of the most significant examples being probably the thermic ring contraction applied to the total synthesis of (±)-Gelsemoxonine. The unique isoxazolidine scaffold also exhibits an impressive potential as a mimic of nucleosides, carbohydrates, PNA, amino acids, and steroid analogs. This review aims to be a comprehensive and general summary of the different isoxazolidine syntheses, their use as starting building blocks for the preparation of natural compounds, and their main biological activities.</description><identifier>ISSN: 0009-2665</identifier><identifier>EISSN: 1520-6890</identifier><identifier>DOI: 10.1021/acs.chemrev.6b00543</identifier><identifier>PMID: 27981833</identifier><identifier>CODEN: CHREAY</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Amino acids ; Anti-Infective Agents ; Anti-Infective Agents - chemical synthesis ; Anti-Inflammatory Agents, Non-Steroidal ; Anti-Inflammatory Agents, Non-Steroidal - chemical synthesis ; Antineoplastic Agents ; Antineoplastic Agents - chemical synthesis ; Benzazepines ; Benzazepines - chemical synthesis ; beta-Lactams ; beta-Lactams - chemical synthesis ; Biological activity ; Carbohydrates ; Carbohydrates - chemical synthesis ; Chemical compounds ; Chemical Sciences ; Chemical synthesis ; Cyclization ; Cycloaddition Reaction ; Isoxazoles ; Isoxazoles - chemical synthesis ; Isoxazoles - chemistry ; Isoxazolidines ; Nucleosides ; Nucleosides - chemical synthesis ; Optimization ; Organic chemistry ; Oxazines ; Oxazines - chemical synthesis ; Oxidation-Reduction ; Peptide Nucleic Acids ; Peptide Nucleic Acids - chemical synthesis ; Peptidomimetics ; Peptidomimetics - chemical synthesis ; Pyridones ; Pyridones - chemical synthesis ; Scaffolds ; Steroids ; Synthesis (chemistry)</subject><ispartof>Chemical reviews, 2016-12, Vol.116 (24), p.15235-15283</ispartof><rights>Copyright © 2016 American Chemical Society</rights><rights>Copyright American Chemical Society Dec 28, 2016</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a506t-35ceca49945f518237ae6523ae027fd540dd187d1d9cecb139afcd4cde81fdf3</citedby><cites>FETCH-LOGICAL-a506t-35ceca49945f518237ae6523ae027fd540dd187d1d9cecb139afcd4cde81fdf3</cites><orcidid>0000-0002-2820-0384 ; 0000-0003-0734-8109</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.chemrev.6b00543$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.chemrev.6b00543$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,776,780,881,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27981833$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.umontpellier.fr/hal-03572301$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Berthet, Mathéo</creatorcontrib><creatorcontrib>Cheviet, Thomas</creatorcontrib><creatorcontrib>Dujardin, Gilles</creatorcontrib><creatorcontrib>Parrot, Isabelle</creatorcontrib><creatorcontrib>Martinez, Jean</creatorcontrib><title>Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry</title><title>Chemical reviews</title><addtitle>Chem. Rev</addtitle><description>The isoxazolidine ring represents one of the privileged structures in medicinal chemistry, and there have been an increasing number of studies on isoxazolidine and isoxazolidine-containing compounds. Optimization of the 1,3-dipolar cycloaddition (1,3-DC), original methods including electrophilic or palladium-mediated cyclization of unsaturated hydroxylamine, has been developed to obtain isoxazolidines. Novel reactions involving the isoxazolidine ring have been highlighted to accomplish total synthesis or to obtain bioactive compounds, one of the most significant examples being probably the thermic ring contraction applied to the total synthesis of (±)-Gelsemoxonine. The unique isoxazolidine scaffold also exhibits an impressive potential as a mimic of nucleosides, carbohydrates, PNA, amino acids, and steroid analogs. This review aims to be a comprehensive and general summary of the different isoxazolidine syntheses, their use as starting building blocks for the preparation of natural compounds, and their main biological activities.</description><subject>Amino acids</subject><subject>Anti-Infective Agents</subject><subject>Anti-Infective Agents - chemical synthesis</subject><subject>Anti-Inflammatory Agents, Non-Steroidal</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - chemical synthesis</subject><subject>Antineoplastic Agents</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Benzazepines</subject><subject>Benzazepines - chemical synthesis</subject><subject>beta-Lactams</subject><subject>beta-Lactams - chemical synthesis</subject><subject>Biological activity</subject><subject>Carbohydrates</subject><subject>Carbohydrates - chemical synthesis</subject><subject>Chemical compounds</subject><subject>Chemical Sciences</subject><subject>Chemical synthesis</subject><subject>Cyclization</subject><subject>Cycloaddition Reaction</subject><subject>Isoxazoles</subject><subject>Isoxazoles - chemical synthesis</subject><subject>Isoxazoles - chemistry</subject><subject>Isoxazolidines</subject><subject>Nucleosides</subject><subject>Nucleosides - chemical synthesis</subject><subject>Optimization</subject><subject>Organic chemistry</subject><subject>Oxazines</subject><subject>Oxazines - chemical synthesis</subject><subject>Oxidation-Reduction</subject><subject>Peptide Nucleic Acids</subject><subject>Peptide Nucleic Acids - chemical synthesis</subject><subject>Peptidomimetics</subject><subject>Peptidomimetics - chemical synthesis</subject><subject>Pyridones</subject><subject>Pyridones - chemical synthesis</subject><subject>Scaffolds</subject><subject>Steroids</subject><subject>Synthesis (chemistry)</subject><issn>0009-2665</issn><issn>1520-6890</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtrGzEUhUVJqR2nv6AQBrJpFuPoMXdGys6Ypja4pBDvhayHozAeOZJtkv76yrHrQhehq4su3zn3oIPQF4KHBFNyo3Qa6ke7inY3rBcYQ8U-oD4BisuaC3yG-hhjUdK6hh46T-kpPwFo8wn1aCM44Yz10WSawov6FVpvfGdvi1HxM_qdb-3SmuJBK-dCawoXYnEfl6rzulCdKX5Y47XvVFuMcwCfNvH1An10qk3283EO0Pzu23w8KWf336fj0axUgOtNyUBbrSohKnBAOGWNsjVQpiymjTNQYWMIbwwxIoMLwoRy2lTaWE6ccWyArg-2j6qV6-hXKr7KoLycjGZyv8MMGsow2ZHMfj2w6xietzZtZI6qbduqzoZtkvmOEBwY8P9Agda8YTnpAF39gz6Fbcx_8UZVtAIQe0N2oHQMKUXrTmEJlvv6ZK5PHuuTx_qy6vLovV2srDlp_vSVgZsDsFf_vfuO5W_uzKcY</recordid><startdate>20161228</startdate><enddate>20161228</enddate><creator>Berthet, Mathéo</creator><creator>Cheviet, Thomas</creator><creator>Dujardin, Gilles</creator><creator>Parrot, Isabelle</creator><creator>Martinez, Jean</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>7X8</scope><scope>7U5</scope><scope>L7M</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-2820-0384</orcidid><orcidid>https://orcid.org/0000-0003-0734-8109</orcidid></search><sort><creationdate>20161228</creationdate><title>Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry</title><author>Berthet, Mathéo ; Cheviet, Thomas ; Dujardin, Gilles ; Parrot, Isabelle ; Martinez, Jean</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a506t-35ceca49945f518237ae6523ae027fd540dd187d1d9cecb139afcd4cde81fdf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Amino acids</topic><topic>Anti-Infective Agents</topic><topic>Anti-Infective Agents - chemical synthesis</topic><topic>Anti-Inflammatory Agents, Non-Steroidal</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - chemical synthesis</topic><topic>Antineoplastic Agents</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Benzazepines</topic><topic>Benzazepines - chemical synthesis</topic><topic>beta-Lactams</topic><topic>beta-Lactams - chemical synthesis</topic><topic>Biological activity</topic><topic>Carbohydrates</topic><topic>Carbohydrates - chemical synthesis</topic><topic>Chemical compounds</topic><topic>Chemical Sciences</topic><topic>Chemical synthesis</topic><topic>Cyclization</topic><topic>Cycloaddition Reaction</topic><topic>Isoxazoles</topic><topic>Isoxazoles - chemical synthesis</topic><topic>Isoxazoles - chemistry</topic><topic>Isoxazolidines</topic><topic>Nucleosides</topic><topic>Nucleosides - chemical synthesis</topic><topic>Optimization</topic><topic>Organic chemistry</topic><topic>Oxazines</topic><topic>Oxazines - chemical synthesis</topic><topic>Oxidation-Reduction</topic><topic>Peptide Nucleic Acids</topic><topic>Peptide Nucleic Acids - chemical synthesis</topic><topic>Peptidomimetics</topic><topic>Peptidomimetics - chemical synthesis</topic><topic>Pyridones</topic><topic>Pyridones - chemical synthesis</topic><topic>Scaffolds</topic><topic>Steroids</topic><topic>Synthesis (chemistry)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berthet, Mathéo</creatorcontrib><creatorcontrib>Cheviet, Thomas</creatorcontrib><creatorcontrib>Dujardin, Gilles</creatorcontrib><creatorcontrib>Parrot, Isabelle</creatorcontrib><creatorcontrib>Martinez, Jean</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>MEDLINE - Academic</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Chemical reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berthet, Mathéo</au><au>Cheviet, Thomas</au><au>Dujardin, Gilles</au><au>Parrot, Isabelle</au><au>Martinez, Jean</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry</atitle><jtitle>Chemical reviews</jtitle><addtitle>Chem. Rev</addtitle><date>2016-12-28</date><risdate>2016</risdate><volume>116</volume><issue>24</issue><spage>15235</spage><epage>15283</epage><pages>15235-15283</pages><issn>0009-2665</issn><eissn>1520-6890</eissn><coden>CHREAY</coden><abstract>The isoxazolidine ring represents one of the privileged structures in medicinal chemistry, and there have been an increasing number of studies on isoxazolidine and isoxazolidine-containing compounds. Optimization of the 1,3-dipolar cycloaddition (1,3-DC), original methods including electrophilic or palladium-mediated cyclization of unsaturated hydroxylamine, has been developed to obtain isoxazolidines. Novel reactions involving the isoxazolidine ring have been highlighted to accomplish total synthesis or to obtain bioactive compounds, one of the most significant examples being probably the thermic ring contraction applied to the total synthesis of (±)-Gelsemoxonine. The unique isoxazolidine scaffold also exhibits an impressive potential as a mimic of nucleosides, carbohydrates, PNA, amino acids, and steroid analogs. This review aims to be a comprehensive and general summary of the different isoxazolidine syntheses, their use as starting building blocks for the preparation of natural compounds, and their main biological activities.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>27981833</pmid><doi>10.1021/acs.chemrev.6b00543</doi><tpages>49</tpages><orcidid>https://orcid.org/0000-0002-2820-0384</orcidid><orcidid>https://orcid.org/0000-0003-0734-8109</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0009-2665
ispartof Chemical reviews, 2016-12, Vol.116 (24), p.15235-15283
issn 0009-2665
1520-6890
language eng
recordid cdi_hal_primary_oai_HAL_hal_03572301v1
source ACS Publications; MEDLINE
subjects Amino acids
Anti-Infective Agents
Anti-Infective Agents - chemical synthesis
Anti-Inflammatory Agents, Non-Steroidal
Anti-Inflammatory Agents, Non-Steroidal - chemical synthesis
Antineoplastic Agents
Antineoplastic Agents - chemical synthesis
Benzazepines
Benzazepines - chemical synthesis
beta-Lactams
beta-Lactams - chemical synthesis
Biological activity
Carbohydrates
Carbohydrates - chemical synthesis
Chemical compounds
Chemical Sciences
Chemical synthesis
Cyclization
Cycloaddition Reaction
Isoxazoles
Isoxazoles - chemical synthesis
Isoxazoles - chemistry
Isoxazolidines
Nucleosides
Nucleosides - chemical synthesis
Optimization
Organic chemistry
Oxazines
Oxazines - chemical synthesis
Oxidation-Reduction
Peptide Nucleic Acids
Peptide Nucleic Acids - chemical synthesis
Peptidomimetics
Peptidomimetics - chemical synthesis
Pyridones
Pyridones - chemical synthesis
Scaffolds
Steroids
Synthesis (chemistry)
title Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T09%3A53%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Isoxazolidine:%20A%20Privileged%20Scaffold%20for%20Organic%20and%20Medicinal%20Chemistry&rft.jtitle=Chemical%20reviews&rft.au=Berthet,%20Mathe%CC%81o&rft.date=2016-12-28&rft.volume=116&rft.issue=24&rft.spage=15235&rft.epage=15283&rft.pages=15235-15283&rft.issn=0009-2665&rft.eissn=1520-6890&rft.coden=CHREAY&rft_id=info:doi/10.1021/acs.chemrev.6b00543&rft_dat=%3Cproquest_hal_p%3E4290044231%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1854245598&rft_id=info:pmid/27981833&rfr_iscdi=true